Tern plc: £3m facility ‘reflects confidence in underlying businesses’ says Progressive

Tern plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Tern Plc (LON:TERN) has successfully negotiated a new funding facility with an investor to provide up to £3m, available for up to 36 months, with an initial £0.5m drawn down.

Progressive Equity Research commented:

The credit facility is intended to protect Tern’s commercial position by supporting further growth and investment in its current portfolio companies. The facility will also strengthen Tern’s negotiating position and moves the company closer to a self-financing model. We see this funding as a sensible move as Tern continues to mature its position and offering. Tern also hosted a Q&A session with Board members Al Sisto and Ian Ritchie, and we reiterate some of the key messages discussed.

▪ New funding structure. Draw down amounts can be repaid either in cash, using proceeds of a full or partial exit of one of its portfolio companies, or alternatively via conversion rights and the issue of new ordinary shares. However, the investor retains the option for the first 10 days following a non-cash payment for the drawdown to be satisfied through the sale of Wyld shares, from the Wyld Escrow facility. The investor will receive warrants equal to 50% of each drawdown. Following the initial advance, the investor received warrants with an exercise price of 6.79p (a 6% premium to the FY22 NAV of 6.4p); if exercised this would raise £375k.

▪ Tern’s management is looking to take advantage of Wyld’s success as a standalone company, following its IPO on NASDAQ First North in 2021. Wyld has built a significant order backlog since the commercial launch. Tern’s management will look to crystalise upside at appropriate stages to provide capital for investment elsewhere and to self-finance.

▪ Third-party investments reflect confidence in underlying businesses and reduce the reliance on Tern for capital. It has been year of two halves for Tern, with valuation uplifts reversed in H2 due to changing valuation metrics in the technology space. While we do not expect any near-term rebound in valuations, we believe that Tern remains well placed to help its portfolio through this phase of difficult macro conditions, and the funding arrangement strengthens Tern’s position in this regard.

▪ Tern’s model has built value and management is committed to providing access to returns through full or partial exits when shareholder value is maximised. Against the challenging macro backdrop, particularly for tech companies, Tern’s underlying metrics are improving. In our view, Tern’s funding-to-exit model requires patience as it navigates economic difficulties: we see the strong recurring revenue growth attracting additional strategic interest and look forward to positive newsflow.

Share on:
Find more news, interviews, share price & company profile here for:

Tern Plc cuts Board pay and introduces shareholder distribution policy

Tern has announced a 50% reduction in fixed remuneration for its Board and executive management from 1 November 2025, expected to save around £153,000 annually. The company has also introduced a new policy linking management pay to investment exits and committed to distributing at least 50% of net proceeds from disposals over £1 million to shareholders, subject to reserves and regulatory requirements.

The architecture powering Zero Trust at the edge

Device Authority is redefining Zero Trust for the connected edge, embedding automated trust anchors into every device from manufacturing to decommissioning.

Tracking resonance at medical congresses

Pharma congresses draw crowds, but Talking Medicines is shifting focus to the harder measure of success, whether messages truly resonate with healthcare professionals.

Tern Plc launches £642k Open Offer at 0.50p per share

Tern Plc has announced an Open Offer to raise up to £642,486 through the issue of 128.5 million new shares at 0.50p each, a 20% discount to the recent market price.

Aligning pharma messaging with real voices

How pharma brands listen, and adapt, to real conversation may determine whether their messaging earns trust or loses relevance.

A security alliance shaping the future of connected infrastructure

Device Authority and Optiv are aligning identity automation with enterprise integration to secure the next wave of connected infrastructure.

Search

Search